NCT03859635View on ClinicalTrials.gov

Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 7, 2019

Primary Completion Date

November 6, 2022

Study Completion Date

November 7, 2022

Conditions
Pain, PostoperativeThoracicAcute Pain
Interventions
DRUG

Liposomal Bupivacaine

20 ml

DRUG

Bupivacaine, 0.25%

10 ml

DRUG

Bupivacaine, 0.5%

30 ml

Trial Locations (1)

46202

Indiana University Hospital, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER

NCT03859635 - Erector Spinae Block Versus Surgeon Infiltration in VATS Procedures | Biotech Hunter | Biotech Hunter